Stockholders' Deficiency Disclosure |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Notes | |
| Stockholders' Deficiency Disclosure | 2.STOCKHOLDERS’ DEFICIENCY
Preferred Stock – The Company is authorized to issue 5,000,000 shares of $0.0001 par value preferred stock. As of March 31, 2026 and 2025, no shares of preferred stock have been issued.
Common Stock – The Company is authorized to issue 100,000,000 shares of $0.0001 par value common stock. As of March 31, 2026 and 2025, 74,491,958 and 62,727,829 shares were issued and outstanding, respectively. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|